The Effect of Alogliptin and Metformin Combination Therapy in Type 2 Diabetes: A Pilot Study

Miyako Kishimoto, Kaori Inoue, Mitsuhiko Noda

Abstract


Background: As type 2 diabetes is characterized by both insulin resistance and impaired insulin secretion, oral anti-diabetic treatments including dipeptidyl peptidase-4 inhibitors, which stimulate insulin secretion, and biguanides, which enhance insulin sensitivity should be considered. Therefore, we performed a pilot study using a combination therapy with agents from both of these classes of drugs. We selected alogliptin and metformin as representative drugs and evaluated their combinational efficacy in patients with type 2 diabetes.

Methods: Continuous glucose monitoring (CGM) was performed throughout the study for two patients with type 2 diabetes and one control subject. First, the subjects received no medication (the 5-day washout period), and later, all subjects received three patterns of medication: alogliptin alone, alogliptin and metformin co-administration, and metformin alone. Blood was sampled before and 1 h after breakfast and lunch on representative days during each treatment condition.

Results: The CGM results indicated that combination of alogliptin and metformin attenuated the escalation and fluctuation of glucose levels. The patterns of insulin and glucagon secretion with alogliptin alone, alogliptin and metformin co-administration, and metformin alone varied among subjects. When alogliptin and metformin were co-administered, glucagon-like peptide-1 (GLP-1) levels 1 h after lunch were higher in all subjects compared to those at any other time point. Postprandial glucose-dependent insulinotropic peptide (GIP) levels varied according to medication and the subject.

Conclusions: Thus, CGM results revealed that a combination of alogliptin and metformin effectively reduced postprandial glucose fluctuation and stabilized blood glucose levels. The study subjects exhibited completely different response patterns of insulin, glucagon, GLP-1, and GIP with medications alone or in combination, suggesting that individual hormone-dependent glycemic responses to these drugs are complicated and multifactorial.




J Endocrinol Metab. 2013;3(4-5):111-118
doi: https://doi.org/10.4021/jem196e


Keywords


Metformin; DPP-4 inhibitor; Glucagon-like peptide-1; Glucose-dependent insulinotropic peptide; Continuous glucose monitoring

Full Text: HTML PDF
 

Browse  Journals  

 

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

 

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

 

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

 

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

 

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 
       
 

Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jofem.org   editorial contact: editor@jofem.org    elmer.editorial2@hotmail.com
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.


Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.